Tempest Therapeutics, Inc. (TPST) SEC Filings — 2024
17 SEC filings for Tempest Therapeutics, Inc. (TPST) in 2024.
Filings
- Tempest Therapeutics Faces Nasdaq Delisting Warning — 8-K · Dec 31, 2024
- Tempest Therapeutics Files 8-K on Definitive Agreement — 8-K · Dec 6, 2024
- Tempest Therapeutics Files Definitive Proxy Statement — DEF 14A · Nov 12, 2024
- Tempest Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Tempest Therapeutics Files 8-K — 8-K · Oct 10, 2024
- Versant Venture Capital VI Amends Tempest Therapeutics Stake — SC 13D/A · Aug 12, 2024
- Tempest Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Horizon to Acquire Tempest Therapeutics for $1/share + CVR — 8-K · Jun 20, 2024
- Tempest Therapeutics Schedules Shareholder Vote for F-star Merger — 8-K · Jun 14, 2024
- Versant Venture Capital VI Amends Stake in Tempest Therapeutics — SC 13D/A · May 13, 2024
- Tempest Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Tempest Therapeutics Announces 2024 Annual Meeting of Stockholders on June 13 — DEF 14A · Apr 23, 2024
- Tempest Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
- Tempest Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Tempest Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- FMR LLC & Abigail Johnson Trim Tempest Therapeutics Stake to 2.244% — SC 13G/A · Feb 9, 2024
- Versant Amends Tempest Therapeutics Stake, Signals Ownership Change — SC 13D/A · Feb 8, 2024